Mind Medicine (MindMed) Inc. (MNMD) NASDAQ

Currency In USD

Mind Medicine (MindMed) Inc.

Address

1055 West Hastings Street

Vancouver, BC V6E 2E9

Canada

Phone

650 208 2454

Website

https://www.mindmed.co

Sector

Healthcare

Industry

Biotechnology

Employees

First IPO Date

November 15, 2016

Key Executives

Name	Title	Pay	Year Born
Robert Barrow	Chief Executive Officer & Director	997,010	1989
Scott Freeman	Co-Founder & Clinical Advisor	309,621	1957
Brandi L. Roberts	Chief Financial Officer	608,624	1974
Mark R. Sullivan	Chief Legal Officer & Corporate Secretary	638,607	1971
Daniel Rollings Karlin	Chief Medical Officer	703,319	1980
Leonard Latchman	Co-founder	0	N/A
Peter Mack	Senior Vice President of Pharmaceutical Development & Operations	0	N/A
Beth Calitri	Vice President of Corporate Communications	0	N/A
Stephanie Fagan	Chief Corporate Affairs Officer	0	N/A
Gregg Pratt	Chief Regulatory & Quality Assurance Officer	0	N/A

Description

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain, and neurological ailments. Among its key pipeline assets is MM-120, currently undergoing Phase 2 clinical trials. This candidate is being investigated for its potential in addressing generalized anxiety disorder, attention deficit hyperactivity disorder (ADHD), and chronic pain. Furthermore, MM-110, an a3ß4 nicotinic cholinergic receptor antagonist, has successfully completed Phase 1 studies for managing opioid withdrawal. The company's portfolio also includes MM-402, an R-enantiomer of 3,4-methylenedioxymethamphetamine, aimed at treating the core symptoms associated with autism spectrum disorder. Its corporate headquarters are situated in Vancouver, Canada.